Categories: News

CGTN: Peng Liyuan addresses video conference on World TB Day 2022

BEIJING, March 24, 2022 /PRNewswire/ — Peng Liyuan, wife of Chinese President Xi Jinping and World Health Organization (WHO) goodwill ambassador for tuberculosis (TB) and HIV/AIDS, attended a video conference for World Tuberculosis Day 2022 on Thursday.

“In recent years, thanks to the hard work of the WHO and the joint efforts of the international community, the world has made notable progress in the fight against TB,” Peng said.

“The Chinese government takes TB prevention and treatment very seriously and has incorporated it into the Healthy China strategy. Special funds have been set up, free follow-up examinations and anti-TB drugs are provided to patients, and more is being done to promote new diagnostic technologies and medicines. As a result, the TB cured rate has been kept above 90 percent,” she said.

Peng noted that the Chinese government and all sectors of society have been actively providing care for TB patients, ensuring that treatment is not affected by the pandemic.

She also shared her experience of being involved in TB prevention and control in the country, as she has visited many medical institutions, schools and communities in the past years.

“In China, more than one million volunteers are working to raise public awareness of TB prevention and treatment and to help and support TB patients,” she said.

March 24 marks the 27th World Tuberculosis Day. As one of the oldest infectious diseases, TB has plagued the world for centuries. Yet despite growing awareness and a stronger resolve to stamp it out, the disease continues to be relentless.

https://news.cgtn.com/news/2022-03-24/Peng-Liyuan-addresses-video-conference-on-World-TB-Day-2022-18EM3kcPNsc/index.html

View original content to download multimedia:https://www.prnewswire.com/news-releases/cgtn-peng-liyuan-addresses-video-conference-on-world-tb-day-2022-301510528.html

SOURCE CGTN

Staff

Recent Posts

Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2024 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 18, 2024) - Medexus Pharmaceuticals (TSX: MDP)…

3 hours ago

InsiteOne Achieves Strong Growth with Six New Contracts Post Acquisition of BRIT Systems Cloud-Native RIS/PACS/VNA

WALLINGFORD, Conn., June 18, 2024 /PRNewswire/ -- InsiteOne, a leading provider of cloud-based Vendor Neutral Archive…

3 hours ago

Young Women’s Christian Association of Bethlehem PA Completes its Investigation of Security Incident

BETHLEHEM, Pa., June 18, 2024 /PRNewswire/ -- Young Women's Christian Association of Bethlehem PA ("YWCA…

3 hours ago

INSIGHTEC ANNOUNCES $150M FINANCING TO FUND CONTINUED GROWTH

Fidelity Management & Research Company Leads Financing; Nexus Neurotech Ventures and Ally Bridge Group Co-Lead…

3 hours ago

IntegriChain Acquires BridgeView Data Solutions, Creating the Pharmaceutical Industry’s Best-in-Class Commercial Data Solution

Combined entity delivers the ICyte® revenue optimization platform powered by first-party data, AI-enabled data exploration,…

3 hours ago

WellBe Senior Medical Earns HITRUST & NIST Certification, Highlighting Commitment to Data Security

CHICAGO, June 18, 2024 /PRNewswire/ -- WellBe Senior Medical and its affiliated medical groups announce…

3 hours ago